Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$25.89 - $29.73 $131,469 - $150,968
-5,078 Reduced 19.71%
20,681 $573,000
Q4 2023

Jan 10, 2024

SELL
$26.13 - $33.94 $1.25 Million - $1.63 Million
-47,968 Reduced 65.06%
25,759 $741,000
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $814,412 - $951,966
-25,379 Reduced 25.61%
73,727 $2.45 Million
Q2 2023

Jul 20, 2023

BUY
$36.12 - $41.79 $215,744 - $249,611
5,973 Added 6.41%
99,106 $3.64 Million
Q1 2023

Apr 12, 2023

SELL
$39.39 - $51.28 $292,943 - $381,369
-7,437 Reduced 7.39%
93,133 $3.8 Million
Q4 2022

Jan 26, 2023

BUY
$41.75 - $54.5 $164,077 - $214,185
3,930 Added 4.07%
100,570 $0
Q3 2022

Oct 20, 2022

BUY
$43.76 - $53.42 $62,095 - $75,802
1,419 Added 1.49%
96,640 $4.23 Million
Q2 2022

Jul 28, 2022

BUY
$46.53 - $55.17 $248,842 - $295,049
5,348 Added 5.95%
95,221 $4.99 Million
Q1 2022

Apr 27, 2022

SELL
$45.75 - $56.69 $146,949 - $182,088
-3,212 Reduced 3.45%
89,873 $4.65 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $189,782 - $281,321
4,593 Added 5.19%
93,085 $5.5 Million
Q3 2021

Nov 02, 2021

BUY
$39.25 - $50.42 $620,385 - $796,938
15,806 Added 21.75%
88,492 $3.81 Million
Q2 2021

Jul 30, 2021

BUY
$35.91 - $40.68 $263,435 - $298,428
7,336 Added 11.23%
72,686 $2.85 Million
Q1 2021

Apr 28, 2021

BUY
$33.49 - $37.77 $914,544 - $1.03 Million
27,308 Added 71.78%
65,350 $2.37 Million
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $1.27 Million - $1.62 Million
38,042 New
38,042 $1.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Baker Tilly Wealth Management, LLC Portfolio

Follow Baker Tilly Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.